Skip to main content
Category

Oxycodone

Report: Consulting Firm, McKinsey, To Pay $650m To Resolve US Opioid Probe Oxycodone

Report: Consulting Firm, McKinsey, To Pay $650m To Resolve US Opioid Probe

McKinsey & Co has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to boost sales, according to a Reuters report. The report said that McKinsey has entered into a five-year deferred…
bubmag
December 16, 2024
Review: ‘Painkiller’ tough, necessary viewing on drug epidemic Oxycodone

Review: ‘Painkiller’ tough, necessary viewing on drug epidemic

Pakistan’s first Global Cuisine Show sparks international delight, appetite for local ingredients  KARACHI: As Pakistan’s first Global Cuisine Show concluded on Saturday, the organizers revealed its purpose was to enhance the country’s exports and introduce international chefs to the potential and quality of locally sourced food ingredients.  The cuisine show…
bubmag
August 13, 2023
Here’s the Most Recent Update on the Sacklers’ OxyContin Scandal as Seen on Painkiller Oxycodone

Here’s the Most Recent Update on the Sacklers’ OxyContin Scandal as Seen on Painkiller

Netflix’s new limited series, Painkiller, stars Matthew Broderick in an unnerving, ripped-from-the-headlines tale of the devastation wrought by the opioid epidemic, and particularly the role that OxyContin played in fueling the crisis. Broderick stars as the real-life Richard Sackler, of the Sackler family that owns Purdue Pharma, the manufacturer of…
bubmag
August 12, 2023
Painkiller: Everything We Know Oxycodone

Painkiller: Everything We Know

The Sackler family took another hit with Netflix's Painkiller, a drama series that focuses on the effects of the opioid crisis in America. The six-episode limited series—which is directed by Friday Night Lights's Peter Berg, and stars Matthew Broderick as Richard Sackler—premiered on August 10. Sackler was the chairman and…
bubmag
August 11, 2023
Supreme Court blocks Purdue Pharma’s massive opioid settlement, will hear challenge Oxycodone

Supreme Court blocks Purdue Pharma’s massive opioid settlement, will hear challenge

The Supreme Court on Thursday blocked, for now, a multi-billion-dollar bankruptcy settlement by Purdue Pharma that would protect its Sackler family owners from civil lawsuits related to the opioid crisis. The Supreme Court also said it will hear a U.S. Bankruptcy trustee's challenge to the settlement by Purdue, the maker…
bubmag
August 11, 2023
Supreme Court blocks Purdue Pharma settlement that would shield Sackler family Oxycodone

Supreme Court blocks Purdue Pharma settlement that would shield Sackler family

Supreme Court blocks Purdue Pharma settlement Supreme Court temporarily blocks Purdue Pharma settlement for opioid lawsuits 04:02 Washington — The Supreme Court on Thursday temporarily blocked a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over…
bubmag
August 10, 2023
Supreme Court Blocks OxyContin Maker’s Bankruptcy Deal That Would Shield Sackler Family Members Oxycodone

Supreme Court Blocks OxyContin Maker’s Bankruptcy Deal That Would Shield Sackler Family Members

The justices agreed to a request from the Biden administration to put the brakes on an agreement reached last year with state and local governments. In addition, the high court will hear arguments before the end of the year over whether the settlement can proceed. The deal would allow the…
bubmag
August 10, 2023
Watch: Payback for the Opioid Crisis: How Did the Sackler Family Skirt Liability? Oxycodone

Watch: Payback for the Opioid Crisis: How Did the Sackler Family Skirt Liability?

This week, a federal appeals court ruling concerning opioid manufacturer Purdue Pharma spared its owner, the Sackler family, from further civil litigation in exchange for a $6 billion settlement. KFF Health News senior correspondent Aneri Pattani appeared on PBS NewsHour to discuss the ruling and her reporting into the ongoing…
bubmag
June 1, 2023